Search Results for "neomycin"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for neomycin. Results 1 to 3 of 3 total matches.

In Brief: Prevention of Measles

   
The Medical Letter on Drugs and Therapeutics • Jun 09, 2025  (Issue 1730)
to neomycin (M-M-R II and Priorix) or hypersensitivity to gelatin (M-M-R II). VACCINE ADVERSE EFFECTS — Pain ...
According to the Centers for Disease Control (CDC), as of April 24 there have been 844 confirmed cases of measles in the US in 2025; 11% of cases have resulted in hospitalization and 3 patients have died. The majority of cases (96%) have been in unvaccinated persons or in those whose vaccination history was unknown
Med Lett Drugs Ther. 2025 Jun 9;67(1730):94-5   doi:10.58347/tml.2025.1730d |  Show IntroductionHide Introduction

Adult Immunization

   
The Medical Letter on Drugs and Therapeutics • Oct 17, 2022  (Issue 1661)
to persons with a history of anaphylaxis caused by neomycin (M-M-R II and Priorix) or gelatin (M-M-R II ...
The Advisory Committee on Immunization Practices (ACIP) recommends use of certain vaccines in adults residing in the US. Routine childhood immunization has reduced the overall incidence of some of these vaccine-preventable diseases, but many adults remain susceptible. Recommendations for vaccination against COVID-19, seasonal influenza, and monkeypox and vaccination of travelers have been reviewed separately.
Med Lett Drugs Ther. 2022 Oct 17;64(1661):161-8 |  Show IntroductionHide Introduction

Influenza Vaccine for 2024-2025

   
The Medical Letter on Drugs and Therapeutics • Sep 16, 2024  (Issue 1711)
-policy. 5. May contain residual amounts of neomycin sulfate, polymyxin B, and hydrocortisone. 6 ...
Annual vaccination in the US against influenza A and B viruses is recommended for everyone ≥6 months old without a contraindication. Influenza vaccines available in the US for the 2024-2025 season are listed in Table 2.
Med Lett Drugs Ther. 2024 Sep 16;66(1711):145-50   doi:10.58347/tml.2024.1711a |  Show IntroductionHide Introduction